dipivefrin has been researched along with Nephrotic Syndrome in 2 studies
dipivefrin: used in treatment of both primary & open angle glaucoma; RN given refers to (+-)-isomer
dipivefrin : The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gargiulo, A | 1 |
| Massella, L | 1 |
| Ruggiero, B | 1 |
| Ravà, L | 1 |
| Ciofi Degli Atti, M | 1 |
| Materassi, M | 1 |
| Lugani, F | 1 |
| Benetti, E | 1 |
| Morello, W | 1 |
| Molino, D | 1 |
| Mattozzi, F | 1 |
| Pennesi, M | 1 |
| Maringhini, S | 1 |
| Pasini, A | 1 |
| Gianoglio, B | 1 |
| Pecoraro, C | 1 |
| Montini, G | 1 |
| Murer, L | 1 |
| Ghiggeri, GM | 1 |
| Romagnani, P | 1 |
| Vivarelli, M | 1 |
| Emma, F | 1 |
| Mahan, JD | 1 |
| Kallash, M | 1 |
| Smoyer, WE | 1 |
1 trial available for dipivefrin and Nephrotic Syndrome
| Article | Year |
|---|---|
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children.
Topics: Anti-Inflammatory Agents; Child; Cross-Over Studies; Epinephrine; Glucocorticoids; Humans; Immunosup | 2021 |
1 other study available for dipivefrin and Nephrotic Syndrome
| Article | Year |
|---|---|
Results of the PROPINE randomized controlled trial: determining the ever-elusive target, the optimal plan for relapses of nephrotic syndrome in children.
Topics: Child; Epinephrine; Humans; Nephrotic Syndrome; Prednisone; Recurrence | 2021 |